Search Results - "Casado, LF"
-
1
PSY72 - Cost-Utility of Idelalisib In Combination with Rituximab In Relapsed or Refractory Chronic Lymphocytic Leukemia
Published in Value in health (01-10-2017)Get full text
Journal Article -
2
Cost-Utility of Idelalisib In Combination with Rituximab In Relapsed or Refractory Chronic Lymphocytic Leukemia
Published in Value in health (01-10-2017)“…OBJECTIVES: The aim of this study is to evaluate the cost-utility of idelalisib in combination with rituximab (IR) versus rituximab (R) monotherapy in the…”
Get full text
Journal Article -
3
Economic evaluation of obinutuzumab in combination with chlorambucil in first-line treatment of patients with chronic lymphocytic leukemia in Spain
Published in ClinicoEconomics and outcomes research (01-01-2016)“…To evaluate the cost-effectiveness of obinutuzumab in combination with chlorambucil (GClb) versus rituximab plus chlorambucil (RClb) in the treatment of adults…”
Get full text
Journal Article -
4
Effect of chemotherapy with alkylating agents on the yield of CD34+ cells in patients with multiple myeloma. Results of the Spanish Myeloma Group (GEM) Study
Published in Haematologica (Roma) (01-05-2006)“…Grupo Espanol de Mieloma. delarubia_jav@gva.es BACKGROUND AND OBJECTIVES: Although alkylating agents are clearly beneficial in multiple myeloma (MM), their…”
Get full text
Journal Article -
5
-
6
Prenatal stroke in a neonate heterozygous for factor V Leiden mutation
Published in Brain & development (Tokyo. 1979) (01-09-2005)“…The authors report an infant with congenital hemiplegia associated to heterozygousity for factor V Leiden. Prenatal stroke in the left cerebral hemisphere was…”
Get full text
Journal Article -
7
High expression of the ILT2 (LIR-1) inhibitory receptor for major histocompatibility complex class I molecules on clonal expansions of T large granular lymphocytes in asymptomatic patients
Published in Haematologica (Roma) (01-05-2001)“…Servicio de Hematologia y Hemoterapia, Hospital Virgen de la Salud, Avenida de Barber 30, Toledo, Spain. lcasado@cht.insalud.es BACKGROUND AND OBJECTIVES. The…”
Get full text
Journal Article -
8
Basilar artery thrombosis in a child heterozygous for factor V Leiden mutation
Published in Pediatric neurology (2001)“…Activated protein C resistance, usually because of factor V Leiden mutation, is considered to be the most common hereditary prothrombotic condition. A…”
Get full text
Journal Article -
9
Interferon alpha for chronic myeloid leukemia relapsing after allogeneic bone marrow transplantation
Published in Bone marrow transplantation (Basingstoke) (01-03-1999)“…Interferon alpha (IFN alpha) induces cytogenetic responses in patients with chronic myeloid leukemia (CML) who relapse after allogeneic bone marrow…”
Get full text
Journal Article -
10
A randomized study of intermediate as compared with high doses of interferon-alpha for chronic myeloid leukemia: no differences in cytogenetic responses
Published in Annals of hematology (01-12-2003)“…Interferon-alpha (IFN-alpha) is a therapy of unquestionable efficacy in chronic myeloid leukemia (CML) patients. The best dose of IFN-alpha in the treatment of…”
Get full text
Journal Article -
11
Familial hairy cell leukemia: a HLA-linked disease or farmers-linked disease?
Published in Haematologica (Roma) (01-08-1998)“…In the 16 cases of familial HCL published, different HLA have been found. Although specific HLA antigens were found to have the same structure in some cases…”
Get full text
Journal Article -
12
-
13
Study of chimerism in long-term survivors after bone marrow transplantation for severe acquired aplastic anemia
Published in Bone marrow transplantation (Basingstoke) (01-08-1996)“…Chimerism studies employing PCR and Southern techniques targeting VNTR loci were performed in 17 severe acquired aplastic anemia patients who were long-term…”
Get more information
Journal Article -
14
Southern technique and cytogenetics are complementary and must be used together in the evaluation of Ph1, M‐BCR positive chronic myeloid leukemia (CML) patients treated with alpha interferon (IFN‐ALPHA)
Published in American journal of hematology (01-11-1996)“…Cytogenetic analysis is the gold standard for the follow‐up of CML patients. The sensitivity of cytogenetics is fairly similar to that of Southern detection of…”
Get full text
Journal Article